VEGFA and mesothelioma: Silencing EphB2 in mesothelioma cell lines resulted in a pronounced reduction in downstream effectors including matrix metalloproteinase-2 and vascular endothelial growth factor, while the expression of pro-apoptotic mediators such as caspase-8 was upregulated.